Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Joshua Gowin to Substance-Related Disorders

This is a "connection" page, showing publications Joshua Gowin has written about Substance-Related Disorders.

 
Connection Strength
 
 
 
1.898
 
  1. Tanabe J, Regner M, Sakai J, Martinez D, Gowin J. Neuroimaging reward, craving, learning, and cognitive control in substance use disorders: review and implications for treatment. Br J Radiol. 2019 Sep; 92(1101):20180942.
    View in: PubMed
    Score: 0.369
  2. Gowin JL, Sloan ME, Ramchandani VA, Paulus MP, Lane SD. Differences in decision-making as a function of drug of choice. Pharmacol Biochem Behav. 2018 01; 164:118-124.
    View in: PubMed
    Score: 0.329
  3. Gowin JL, Ball TM, Wittmann M, Tapert SF, Paulus MP. Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse. Drug Alcohol Depend. 2015 Jul 01; 152:93-101.
    View in: PubMed
    Score: 0.279
  4. Gowin JL, Mackey S, Paulus MP. Altered risk-related processing in substance users: imbalance of pain and gain. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):13-21.
    View in: PubMed
    Score: 0.243
  5. Gowin JL, Green CE, Alcorn JL, Swann AC, Moeller FG, Lane SD. Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior. J Psychopharmacol. 2012 Jul; 26(7):982-93.
    View in: PubMed
    Score: 0.214
  6. Stellern J, Xiao KB, Grennell E, Sanches M, Gowin JL, Sloan ME. Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction. 2023 01; 118(1):30-47.
    View in: PubMed
    Score: 0.116
  7. Gowin J, Sloan ME, Swan JE, Momenan R, Ramchandani VA. The relationship between delay discounting and alcohol dependence in individuals with and without comorbid psychopathology. Psychopharmacology (Berl). 2019 Feb; 236(2):775-785.
    View in: PubMed
    Score: 0.089
  8. Sloan ME, Gowin JL, Ramchandani VA, Hurd YL, Le Foll B. The endocannabinoid system as a target for addiction treatment: Trials and tribulations. Neuropharmacology. 2017 Sep 15; 124:73-83.
    View in: PubMed
    Score: 0.081
  9. Pariyadath V, Gowin JL, Stein EA. Resting state functional connectivity analysis for addiction medicine: From individual loci to complex networks. Prog Brain Res. 2016; 224:155-73.
    View in: PubMed
    Score: 0.072
  10. Alcorn JL, Gowin JL, Green CE, Swann AC, Moeller FG, Lane SD. Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder. J Neuropsychiatry Clin Neurosci. 2013; 25(3):229-32.
    View in: PubMed
    Score: 0.059
  11. Lane SD, Gowin JL, Green CE, Steinberg JL, Moeller F, Cherek DR. Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior. Pharmacol Biochem Behav. 2009 Apr; 92(2):357-62.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)